531752 Stock Overview
Biogen Pharmachem Industries Limited engages in the trading of shares and securities.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Biogen Pharmachem Industries Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1.13 |
| 52 Week High | ₹1.85 |
| 52 Week Low | ₹0.62 |
| Beta | -0.23 |
| 1 Month Change | 2.73% |
| 3 Month Change | -15.67% |
| 1 Year Change | 59.15% |
| 3 Year Change | 352.00% |
| 5 Year Change | 370.83% |
| Change since IPO | 109.26% |
Recent News & Updates
Recent updates
Shareholder Returns
| 531752 | IN Capital Markets | IN Market | |
|---|---|---|---|
| 7D | -1.7% | 1.2% | 1.6% |
| 1Y | 59.2% | 103.7% | 45.1% |
Return vs Industry: 531752 underperformed the Indian Capital Markets industry which returned 103.7% over the past year.
Return vs Market: 531752 exceeded the Indian Market which returned 45.1% over the past year.
Price Volatility
| 531752 volatility | |
|---|---|
| 531752 Average Weekly Movement | 7.7% |
| Capital Markets Industry Average Movement | 6.8% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.0% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 531752's share price has been volatile over the past 3 months.
Volatility Over Time: 531752's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | n/a | Niraj Vaghela | www.biogenpharma.shop |
Biogen Pharmachem Industries Limited engages in the trading of shares and securities. The company was formerly known as Sun Techno Overseas Limited and changed its name to Biogen Pharmachem Industries Limited in March 2021. Biogen Pharmachem Industries Limited was incorporated in 1995 and is based in Rajkot, India.
Biogen Pharmachem Industries Limited Fundamentals Summary
| 531752 fundamental statistics | |
|---|---|
| Market cap | ₹737.44m |
| Earnings (TTM) | ₹9.93m |
| Revenue (TTM) | ₹10.14m |
74.3x
P/E Ratio72.7x
P/S RatioIs 531752 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 531752 income statement (TTM) | |
|---|---|
| Revenue | ₹10.14m |
| Cost of Revenue | ₹0 |
| Gross Profit | ₹10.14m |
| Other Expenses | ₹216.00k |
| Earnings | ₹9.93m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.015 |
| Gross Margin | 100.00% |
| Net Profit Margin | 97.87% |
| Debt/Equity Ratio | 9.9% |
How did 531752 perform over the long term?
See historical performance and comparison